Colorectal cancer (CRC) remains difficult to treat, particularly after resistance to targeted therapies and immunotherapy ...

At last week’s World Congress on Pain, Kinoxis Therapeutics Pty and the University of Sydney reported data regarding their ...

Researchers are taking new steps to improve CAR T-cell therapies by better understanding their behavior and engineering them to overcome some of their limitations, from treatment failure and T-cell ...

Prostate-specific membrane antigen (PSMA) is overexpressed in primary and metastatic prostate cancer, including metastatic lesions in lymph nodes and bone, compared with normal prostate tissues. ADC ...

Highslab Therapeutics Inc. recently provided details on HL-7037, a cyclic peptide designed to selectively target glypican-3 ...

Blackstone Life Sciences entered into a $455 million deal with Boston Scientific Corp. to co-fund the development of Vitalyst ...

Fresenius SE & Co. KGaA has secured exclusive options to develop up to 37 biosimilars with Wuxi Biologics Co. Ltd. in a ...

Royal Philips NV has reached an agreement in principle with the U.S. Department of Justice (DOJ) to resolve criminal and ...

A lot is on the line Nov. 3 as Americans who hadn’t voted yet headed to the polls for the official, and final, day of the U.S. midterm election. In casting ballots to support their candidates for ...

At Bioplus Interphex Korea 2026 in Seoul, panelists noted that “transformative” technological architecture, including large ...

A person’s DNA sequence is largely the same across cells, but the effects of genetic variation can differ sharply. Three ...

Sharing the spotlight with more-dismal cancer types at the European Society for Medical Oncology (ESMO) meeting in Madrid ...